Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Assessing brain activity patterns to predict postoperative delirium

Official title: Bilateral Bispectral Index and Asymmetries in High Risk Patients for Posteoperative Delirium: An Observational, Prospective, Exploratory Study

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06761573 · Data updated 2026-11-12

This study is testing if monitoring brain activity during head and neck or plastic surgery can help predict if patients will experience confusion or memory problems afterwards.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment84 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedJuly 7, 2020
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 7, 2025
Trial IDNCT06761573 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients over 70 years old or those with specific risk factors undergoing head and neck surgery.

Probably not a fit

Patients with severe anesthetic risk or significant neurological history may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the interhemispheric asymmetry of brain activity using the Bilateral Bispectral Index in patients undergoing head and neck or plastic surgery. It will monitor patients at various stages during and after surgery to determine the relationship between brain activity patterns and the development of postoperative delirium (POD) and cognitive dysfunction (POCD). Patients will be followed for 30 days post-surgery for POD and 90 days for POCD, using specific diagnostic scales to assess outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved prediction and management of postoperative delirium and cognitive dysfunction in at-risk surgical patients.

How similar studies have gone: While studies on postoperative delirium exist, this specific approach using bilateral bispectral index monitoring is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

-Patients, undergoing head\&neck surgery, who have at least 3 of the following criteria (to establish "a priori" increased risk of POD):

* Age\> 70;
* Male sex; or ASA III;
* Smoker;
* High blood pressure;

Exclusion Criteria:

* ASA IV, V or ASA IE, IIE, IIIE (patients with anesthetic risk ASA\>III and those undergoing urgent-emergency surgery will be excluded from the study);
* Past positive medical history for:

  * Stroke;
  * Dementia;
  * Cerebral aneurysm;
  * Intracranial mass;
  * Head trauma;
  * Epilepsy;
  * Diabetes mellitus;
  * Previous neurosurgical intervention;
  * Psychiatric illnesses requiring chronic treatment;
* Patients undergoing surgery in the previous two weeks;
* Patients whose hospitalization duration is estimated to be less than five days;
* Lack of understanding of the Italian language or English;
* Age \<18 years.

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Maria Paola Lauretta, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Maria Paola Lauretta, MD
  • Email: mariapaola.lauretta@aosp.bo.it
  • Phone: 0512143444

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.